EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a High-Throughput Platform for Quantitation of Histone Modifications on a New QTOF Instrument

Emily Zahn, Yixuan Xie, Xingyu Liu, Rashmi Karki, Richard M Searfoss, Francisca N de Luna Vitorino, Joanna K Lempiäinen, Joanna Gongora, Zongtao Lin, Chenfeng Zhao, Zuo-Fei Yuan, Benjamin A Garcia

Molecular & Cellular Proteomics · 2025

DOI: 10.1016/j.mcpro.2024.100897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025. Verfasst von Emily Zahn und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, Missouri, United States. Hauptthemen laut MEDLINE: Histones, Protein Processing, Post-Translational, High-Throughput Screening Assays, Mass Spectrometry. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NICHD NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone post-translational modifications (PTMs) regulate gene expression patterns through epigenetic mechanisms. The five histone proteins (H1, H2A, H2B, H3, and H4) are extensively modified, with over 75 distinct modification types spanning more than 200 sites. Despite strong advances in mass spectrometry (MS)-based approaches, identification and quantification of modified histone peptides remains challenging because of factors, such as isobaric peptides, pseudo-isobaric PTMs, and low stoichiometry of certain marks. Here, we describe the development of a new high-throughput method to identify and quantify over 150 modified histone peptides by LC-MS. Fast gradient microflow liquid chromatography and variable window sequential windows acquisition of all theoretical spectra data-independent acquisition on a new quadrupole time-of-flight platform is compared to a previous method using nanoflow LC-MS on an Orbitrap hybrid. Histones extracted from cells treated with either a histone deacetylase inhibitor or transforming growth factor-beta 1 were analyzed by data-independent acquisition on two mass spectrometers: an Orbitrap Exploris 240 with a 55-min nanoflow LC gradient and the SCIEX ZenoTOF 7600 with a 10-min microflow gradient. To demonstrate the reproducibility and speed advantage of the method, 100 consecutive injections of one sample were performed in less than 2 days on the quadrupole time-of-flight platform. The result is the comprehensive characterization of histone PTMs achieved in less than 20 min of total run time using only 200 ng of sample. Results for drug-treated histone samples are comparable to those produced by the previous method and can be achieved using less than one-third of the instrument time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesProtein Processing, Post-TranslationalHigh-Throughput Screening AssaysMass SpectrometryHumansHistone Deacetylase InhibitorsChromatography, LiquidProteomicsPeptides

Stichwörter der Autor:innen

DIAepigeneticshistonemass spectrometrypost-translational modification

Substanzen

HistonesHistone Deacetylase InhibitorsPeptides

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, Missouri, United States.
  • Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, Missouri, United States; State Key Laboratory of Genetic Engineering, Greater Bay Area Institute of Precision Medi…
  • Department of Computer Science and Engineering, Washington University in St Louis, St Louis, Missouri, United States.
  • Center for Proteomics and Metabolomics, St Jude Children's Research Hospital, Memphis, Tennessee, United States.
  • Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, Missouri, United States. Electronic address: bagarcia@wustl.edu.

Förderung

  • NIA NIH HHS
  • NICHD NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Zahn, E., Xie, Y., Liu, X., Karki, R., Searfoss, R. M., de Luna Vitorino, F. N., Lempiäinen, J. K., Gongora, J., Lin, Z., Zhao, C., Yuan, Z. F., & Garcia, B. A. (2025). Development of a High-Throughput Platform for Quantitation of Histone Modifications on a New QTOF Instrument. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2024.100897

Vancouver

Zahn E, Xie Y, Liu X, Karki R, Searfoss RM, de Luna Vitorino FN, et al. Development of a High-Throughput Platform for Quantitation of Histone Modifications on a New QTOF Instrument. Molecular & Cellular Proteomics. 2025. doi:10.1016/j.mcpro.2024.100897

BibTeX
@article{Zahn2025,
  author = {Zahn, Emily and Xie, Yixuan and Liu, Xingyu and Karki, Rashmi and Searfoss, Richard M and de Luna Vitorino, Francisca N and Lempiäinen, Joanna K and Gongora, Joanna and Lin, Zongtao and Zhao, Chenfeng and Yuan, Zuo-Fei and Garcia, Benjamin A},
  title = {Development of a High-Throughput Platform for Quantitation of Histone Modifications on a New QTOF Instrument},
  journal = {Molecular & Cellular Proteomics},
  year = {2025},
  doi = {10.1016/j.mcpro.2024.100897}
}
Kostenlos starten →